Epigamia to build larger plant as factories near full capacity amid value-added dairy boom
Verlinvest-backed Epigamia plans a new manufacturing plant, funded internally, as its 8 factories run at 85% utilization. The move follows 50%+ revenue growth to ₹180 crore in FY24, while competition intensifies with Milky Mist's IPO, Amul investments and new-age rivals.
Verlinvest-backed dairy brand Epigamia plans a larger manufacturing plant as existing factories near full capacity, funded internally without new fundraise. Value-added dairy competition intensifies with Milky Mist IPO, Amul investments and new-age rivals across India.
Why this matters
Epigamia's capacity expansion signals confidence after 50%+ FY24 revenue growth to ₹180 crore, positioning the Verlinvest-backed brand against Milky Mist's IPO, Amul investments and new-age rivals in value-added dairy.
Retail-brand signals steady at 2,508 over the past 90 days.
Also reported by
- Mint · Companies — Same time